Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share News

12345678910

GSK subsidiary Tesaro sues AnaptysBio over Jemperli license breach

21st Nov 2025 04:31

(Alliance News) - GSK PLC on Thursday announced that its subsidiary Tesaro has filed a lawsuit against AnaptysBio Inc, alleging material breach of their license agreement. Read More

GSK and Fleming Initiative in GBP45 million AI-driven research push

19th Nov 2025 09:33

(Alliance News) - GSK PLC and Fleming Initiative on Wednesday unveiled six major research programmes aimed at tackling antimicrobial resistance, committing GBP45 million to projects that will harness advanced artificial intelligence and cutting-edge laboratory science to combat drug-resistant infections. Read More

LONDON MARKET CLOSE: Stocks fall amid weak GDP print ahead of budget

13th Nov 2025 17:01

(Alliance News) - The FTSE 100 on Thursday fell back from recent record highs weighed by soft economic data, mixed earnings and a batch of index heavyweights going ex-dividend. Read More

LONDON BROKER RATINGS: Goldman Sachs cuts Weir; UBS ups British Land

7th Nov 2025 10:14

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More

UK dividends calendar - next 7 days

6th Nov 2025 14:18

Read More

LONDON MARKET CLOSE: Stocks mixed and pound dips amid budget tax hints

4th Nov 2025 16:59

(Alliance News) - The FTSE 100 outperformed European and US peers on Tuesday, but sterling fell further, as Chancellor Rachel Reeves laid the groundwork for further tax rises in this month’s budget. Read More

LONDON BROKER RATINGS: Shore Capital cuts Next; Bernstein cuts Ryanair

4th Nov 2025 10:04

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More

LONDON BROKER RATINGS: UBS starts Drax with 'sell'; WPP targets cut

31st Oct 2025 10:07

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More

LONDON MARKET CLOSE: WPP woes keep lid on FTSE and pound extends falls

30th Oct 2025 17:09

(Alliance News) - The FTSE 100 extended its winning run to nine, recouping early hefty falls, despite fresh problems for advertising group, WPP. Read More

LONDON BROKER RATINGS: UBS cuts Ibstock; Deutsche Bank says 'buy' PHP

30th Oct 2025 09:56

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday: Read More

LONDON BRIEFING: Shell launches new buyback; WPP cuts revenue outlook

30th Oct 2025 07:51

(Alliance News) - Shell launches new USD3.5 billion buyback, WPP cuts its outlook while Permanent TSB puts itself up for sale. Read More

LONDON MARKET CLOSE: Stocks mixed ahead of Fed call, Trump-Xi talks

29th Oct 2025 17:10

(Alliance News) - Stock prices in London closed mostly higher on Wednesday, as the US Federal Reserve's interest rate decision comes closer. Read More

LONDON MARKET MIDDAY: FTSE 100 hits new record amid strong results

29th Oct 2025 12:10

(Alliance News) - Stock prices in London were higher at midday on Wednesday, as the FTSE 100 achieved a new record and outperformed European peers after healthy results for GSK and Next. Read More

LONDON MARKET OPEN: FTSE 100 hits high as Next and GSK raise guidance

29th Oct 2025 09:01

(Alliance News) - Stock prices in London opened higher on Wednesday and hit a new intra-day record after a swathe of well-received reports from Glencore, Next and GSK. Read More

GSK lifts sales and profit outlook as Specialty Medicines unit shines

29th Oct 2025 08:51

(Alliance News) - GSK PLC on Wednesday raised guidance after a strong third quarter, which saw sales in all three divisions beat expectations. Read More

LONDON BRIEFING: GSK ups 2025 outlook; Next sales beat guidance

29th Oct 2025 07:50

(Alliance News) - GSK raises its outlook for revenue and profit, Next ups its guidance as third quarter sales beat expectations, while Primary Health Properties' acquisition of Assura is cleared by the UK competition regulator. Read More

GSK strikes license deal with Empirico; gets cancer drug designation

28th Oct 2025 09:23

(Alliance News) - GSK on Tuesday said it will pay up to USD745 million, plus royalties, as part of a license deal with US biotechnology company Empirico Inc. Read More

LONDON BROKER RATINGS: Jefferies raises GSK and AstraZeneca to 'buy'

27th Oct 2025 09:45

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: Read More

LONDON MARKET OPEN: FTSE lags rally amid US-China trade optimism

27th Oct 2025 09:02

(Alliance News) - Stock prices in London were mixed on Monday morning, as the UK lagged a broader rally amid hopes of a trade deal between the US and China. Read More

GSK buys exclusive rights from Syndivia for ADC in prostate cancer

27th Oct 2025 08:52

(Alliance News) - GSK PLC on Monday announced an agreement with Syndivia that grants GSK exclusive worldwide rights to develop and commercialise a preclinical antibody-drug conjugate for metastatic castration-resistant prostate cancer. Read More

12345678910
FTSE 100 Latest
Value9,539.71
Change12.06